BIOGEN INC. (BIIB) Operating income 2012–2021
BIOGEN INC. (BIIB) annual operating income history from SEC filings — each fiscal year as reported.
$2.8BFY2021 · since FY2012: $1.9B → $2.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $2.8B | -37.6% |
| FY2020 | $4.6B | -35.4% |
| FY2019 | $7.0B | +19.6% |
| FY2018 | $5.9B | +10.2% |
| FY2017 | $5.3B | +3.8% |
| FY2016 | $5.2B | +5.3% |
| FY2015 | $4.9B | +23.1% |
| FY2014 | $4.0B | +57.9% |
| FY2013 | $2.5B | +35.5% |
| FY2012 | $1.9B | — |
Source: SEC XBRL filings · For reference only · Not investment advice